Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis

To study the clinical efficiency of using mesodiencephalic modulation (MDM) as therapy in the combination treatment of patients with pulmonary tuberculosis, the authors examined two groups: 1) the patients who received a MDM cycle in combination with chemotherapy regimens (a study group); 2) those t...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Kornienko, G. V. Efron, V. A. Pavlov, G. S. Balasanyants, O. V. Velikaya, M. V. Trukhacheva
Format: Article
Language:Russian
Published: New Terra Publishing House 2015-02-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/342
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850283811262169088
author S. V. Kornienko
G. V. Efron
V. A. Pavlov
G. S. Balasanyants
O. V. Velikaya
M. V. Trukhacheva
author_facet S. V. Kornienko
G. V. Efron
V. A. Pavlov
G. S. Balasanyants
O. V. Velikaya
M. V. Trukhacheva
author_sort S. V. Kornienko
collection DOAJ
description To study the clinical efficiency of using mesodiencephalic modulation (MDM) as therapy in the combination treatment of patients with pulmonary tuberculosis, the authors examined two groups: 1) the patients who received a MDM cycle in combination with chemotherapy regimens (a study group); 2) those treated using standard chemotherapy regimens (a control group). By the end of one-month therapy, the study group ceased bacterial excretion twice more often than the control group that exhibited the similar results only by the end of three-month treatment. MDM as therapy produced positive X-ray changes in 76.0% of the cases in the study group and in 44.4% in the control one. MDM used in the combination treatment of patients with tuberculosis makes it possible to reduce the length of hospital stay, the number of round-the-clock beds, and the cost of treating these patients.
format Article
id doaj-art-48002b37c7014f0eb2e85184a72b36fb
institution OA Journals
issn 2075-1230
2542-1506
language Russian
publishDate 2015-02-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-48002b37c7014f0eb2e85184a72b36fb2025-08-20T01:47:42ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062015-02-0102555910.21292/2075-1230-2015-0-2-55-59342Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosisS. V. Kornienko0G. V. Efron1V. A. Pavlov2G. S. Balasanyants3O. V. Velikaya4M. V. Trukhacheva5КУЗ «Воронежский областной клинический противотуберкулезный диспансер им. Н. С. Похвисневой»КУЗ «Воронежский областной клинический противотуберкулезный диспансер им. Н. С. Похвисневой»КУЗ «Воронежский областной клинический противотуберкулезный диспансер им. Н. С. Похвисневой»Санкт-Петербургский НИИ фтизиопульмонологииВоронежская государственная медицинская академия им Н. Н. БурденкоКУЗ «Воронежский областной клинический противотуберкулезный диспансер им. Н. С. Похвисневой»To study the clinical efficiency of using mesodiencephalic modulation (MDM) as therapy in the combination treatment of patients with pulmonary tuberculosis, the authors examined two groups: 1) the patients who received a MDM cycle in combination with chemotherapy regimens (a study group); 2) those treated using standard chemotherapy regimens (a control group). By the end of one-month therapy, the study group ceased bacterial excretion twice more often than the control group that exhibited the similar results only by the end of three-month treatment. MDM as therapy produced positive X-ray changes in 76.0% of the cases in the study group and in 44.4% in the control one. MDM used in the combination treatment of patients with tuberculosis makes it possible to reduce the length of hospital stay, the number of round-the-clock beds, and the cost of treating these patients.https://www.tibl-journal.com/jour/article/view/342tuberculosiselectrotherapypathogenetic therapyeconomic impact
spellingShingle S. V. Kornienko
G. V. Efron
V. A. Pavlov
G. S. Balasanyants
O. V. Velikaya
M. V. Trukhacheva
Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
Туберкулез и болезни лёгких
tuberculosis
electrotherapy
pathogenetic therapy
economic impact
title Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
title_full Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
title_fullStr Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
title_full_unstemmed Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
title_short Experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
title_sort experience with mesodiencephalic modulation in the combination treatment of patients with tuberculosis
topic tuberculosis
electrotherapy
pathogenetic therapy
economic impact
url https://www.tibl-journal.com/jour/article/view/342
work_keys_str_mv AT svkornienko experiencewithmesodiencephalicmodulationinthecombinationtreatmentofpatientswithtuberculosis
AT gvefron experiencewithmesodiencephalicmodulationinthecombinationtreatmentofpatientswithtuberculosis
AT vapavlov experiencewithmesodiencephalicmodulationinthecombinationtreatmentofpatientswithtuberculosis
AT gsbalasanyants experiencewithmesodiencephalicmodulationinthecombinationtreatmentofpatientswithtuberculosis
AT ovvelikaya experiencewithmesodiencephalicmodulationinthecombinationtreatmentofpatientswithtuberculosis
AT mvtrukhacheva experiencewithmesodiencephalicmodulationinthecombinationtreatmentofpatientswithtuberculosis